{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:44:31Z","timestamp":1792817071248,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12033-023-00867-z","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T07:01:57Z","timestamp":1694847717000},"page":"2362-2380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reverse Vaccinology and\u00a0Immunoinformatic Approach for\u00a0Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses"],"prefix":"10.1007","volume":"66","author":[{"given":"Neda","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Hamidi-fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Motevalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-4907","authenticated-orcid":false,"given":"Golnaz","family":"Bahramali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"867_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/HMER.S352568","volume":"14","author":"GF Malik","year":"2022","unstructured":"Malik, G. F., Zakaria, N., Majeed, M. I., & Ismail, F. W. (2022). Viral hepatitis\u2014the road traveled and the journey remaining. Hepatic Medicine: Evidence And Research, 14, 13\u201326.","journal-title":"Hepatic Medicine: Evidence And Research"},{"key":"867_CR2","first-page":"167","volume":"17","author":"SM Lemon","year":"2017","unstructured":"Lemon, S. M., Ott, J. J., Van Damme, P., & Shouval, D. (2017). Type a viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. Journal of Hepatology, 17, 167\u2013184.","journal-title":"Journal of Hepatology"},{"key":"867_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gtc.2020.01.002","volume":"49","author":"A Abutaleb","year":"2020","unstructured":"Abutaleb, A., & Kottilil, S. (2020). Hepatitis A: Epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterology Clinics of North America, 49, 191\u2013199.","journal-title":"Gastroenterology Clinics of North America"},{"key":"867_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3748\/wjg.v27.i16.1691","volume":"27","author":"D Castaneda","year":"2021","unstructured":"Castaneda, D., Gonzalez, A. J., Alomari, M., Tandon, K., & Zervos, X. B. (2021). From hepatitis a to E: A critical review of viral hepatitis. World Journal of Gastroenterology, 27, 1691\u20131715.","journal-title":"World Journal of Gastroenterology"},{"key":"867_CR5","doi-asserted-by":"publisher","first-page":"2073146","DOI":"10.1080\/21645515.2022.2073146","volume":"18","author":"S Badur","year":"2022","unstructured":"Badur, S., Ozturk, S., AbdelGhany, M., Khalaf, M., Lagoubi, Y., Ozudogru, O., Hanif, K., & Saha, D. (2022). Hepatitis a in the Eastern Mediterranean Region: A comprehensive review. Human Vaccines & Immunotherapeutics, 18, 2073146.","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"867_CR6","unstructured":"(2019). World Health Organization . The Immunological Basis for Immunization Series: Module 18: Hepatitis A."},{"key":"867_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/hepatmon.44695","volume":"17","author":"M Safiabadi","year":"2017","unstructured":"Safiabadi, M., Rezaee-Zavareh, M. S., & Alavian, S. M. (2017). Estimation of hepatitis a virus infection prevalence among eastern mediterranean and middle eastern countries: A systematic review and pooled analysis. Hepatitis Monthly, 17, 1\u20138.","journal-title":"Hepatitis Monthly"},{"key":"867_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.trstmh.2012.05.013","volume":"106","author":"SR Mohebbi","year":"2012","unstructured":"Mohebbi, S. R., Rostami Nejad, M., Tahaei, S. M., Pourhoseingholi, M. A., Habibi, M., Azimzadeh, P., Naghoosi, H., Karayiannis, P., & Zali, M. R. (2012). Seroepidemiology of hepatitis a and E virus infections in Tehran, Iran: A population based study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106, 528\u2013531.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"867_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/hepatmon.66915","volume":"18","author":"A Ramezani","year":"2018","unstructured":"Ramezani, A., Aghasadeghi, M. R., Mamishi, S., Sabeti, S., Bidari-Zerehpoosh, F., Banifazl, M., Bavand, A., Shadanlou, S., & Aghakhani, A. (2018). Seroprevalence of hepatitis a among children and young adults residing in Tehran, Iran: Implication for Hav vaccination. Hepatitis Monthly, 18, 1\u20136.","journal-title":"Hepatitis Monthly"},{"key":"867_CR10","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2020.08.071","volume":"38","author":"KB Lankarani","year":"2020","unstructured":"Lankarani, K. B., Honarvar, B., Molavi Vardanjani, H., Kharmandar, A., Gouya, M. M., Zahraei, S. M., Baneshi, M. R., Ali-Akbarpour, M., Kazemi, M., Seif, M., Fard, S. A. Z., & Emami, A. (2020). Immunity to hepatitis-a virus: A nationwide population-based seroprevalence study from Iran. Vaccine, 38, 7100\u20137107.","journal-title":"Vaccine"},{"key":"867_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/archcid.118869","volume":"16","author":"A Bakhshipour","year":"2021","unstructured":"Bakhshipour, A., Sargolzaie, N., & Rafaiee, R. (2021). Status of immunity against the hepatitis a virus in healthy population: A report from Southeastern Iran. Arch Clin Infect Dis, 16, 1\u20136.","journal-title":"Arch Clin Infect Dis"},{"key":"867_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/CMR.14.1.38-58.2001","volume":"14","author":"JA Cuthbert","year":"2001","unstructured":"Cuthbert, J. A. (2001). Hepatitis A: Old and new. Clinical Microbiology Reviews, 14, 38\u201358.","journal-title":"Clinical Microbiology Reviews"},{"key":"867_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724877","volume":"12","author":"E Van Damme","year":"2021","unstructured":"Van Damme, E., Vanhove, J., Severyn, B., Verschueren, L., & Pauwels, F. (2021). The hepatitis B virus interactome: A comprehensive overview. Frontiers in Microbiology, 12, 724877.","journal-title":"Frontiers in Microbiology"},{"key":"867_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-19","author":"H Nguyen Mindie","year":"2020","unstructured":"Nguyen Mindie, H., Wong, G., Gane, E., Kao, J.-H., & Dusheiko, G. (2020). Hepatitis B virus: Advances in prevention, diagnosis, and therapy. Clinical Microbiology Reviews. https:\/\/doi.org\/10.1128\/CMR.00046-19","journal-title":"Clinical Microbiology Reviews"},{"key":"867_CR15","unstructured":"(2017). World Health Organization . Global Hepatitis Report 2017. Geneva."},{"key":"867_CR16","unstructured":"(2015). World Health Organization . Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva."},{"key":"867_CR17","first-page":"410","volume":"14","author":"A Bahrami","year":"2022","unstructured":"Bahrami, A., Pourfathollah, A. A., Parsania, M., Mehrabi Habibabadi, H., & Sharifi, Z. (2022). Prevalence of occult hepatitis B virus infection among the blood donors in Golestan Province: Cross-sectional study. Iran J Microbiol, 14, 410\u2013416.","journal-title":"Iran J Microbiol"},{"key":"867_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBDHB Collaborators","year":"2022","unstructured":"Collaborators, G. B. D. H. B. (2022). Global, regional, and national burden of hepatitis B, 1990\u20132019: A systematic analysis for the global burden of disease study 2019. The Lancet Gastroenterology & Hepatology, 7, 796\u2013829.","journal-title":"The Lancet Gastroenterology & Hepatology"},{"key":"867_CR19","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.3748\/wjg.v27.i26.4182","volume":"27","author":"P Veronese","year":"2021","unstructured":"Veronese, P., Dodi, I., Esposito, S., & Indolfi, G. (2021). Prevention of vertical transmission of hepatitis B virus infection. World Journal of Gastroenterology, 27, 4182\u20134193.","journal-title":"World Journal of Gastroenterology"},{"key":"867_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v15010214","volume":"15","author":"A Elbahrawy","year":"2023","unstructured":"Elbahrawy, A., Atalla, H., Alboraie, M., Alwassief, A., Madian, A., El Fayoumie, M., Tabll, A. A., & Aly, H. H. (2023). Recent advances in protective vaccines against hepatitis viruses: A narrative review. Viruses, 15, 1\u201323.","journal-title":"Viruses"},{"key":"867_CR21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21645515.2020.1732166","volume":"16","author":"H Zhao","year":"2020","unstructured":"Zhao, H., Zhou, X., & Zhou, Y. H. (2020). Hepatitis B vaccine development and implementation. Human Vaccines & Immunotherapeutics, 16, 1533\u20131544.","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"867_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.vaccine.2021.01.038","volume":"40","author":"A Andani","year":"2022","unstructured":"Andani, A., van Damme, P., Bunge, E. M., Salgado, F., van Hoorn, R. C., & Hoet, B. (2022). One or two doses of hepatitis a vaccine in universal vaccination programs in children in 2020: A systematic review. Vaccine, 40, 196\u2013205.","journal-title":"Vaccine"},{"key":"867_CR23","unstructured":"Savoy, M. L. (2022). Hepatitis a (Hepa)Vaccine,Msd."},{"key":"867_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12934-022-01780-x","volume":"21","author":"A Nain","year":"2022","unstructured":"Nain, A., Kumar, M., & Banerjee, M. (2022). Oligomers of hepatitis a virus (Hav) capsid protein Vp1 generated in a heterologous expression system. Microbial Cell Factories, 21, 53\u201365.","journal-title":"Microbial Cell Factories"},{"key":"867_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.virol.2009.04.004","volume":"388","author":"T Senger","year":"2009","unstructured":"Senger, T., Sch\u00e4dlich, L., Gissmann, L., & M\u00fcller, M. (2009). Enhanced papillomavirus-like particle production in insect cells. Virology, 388, 344\u2013353.","journal-title":"Virology"},{"key":"867_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a031807","volume":"9","author":"DI Stuart","year":"2019","unstructured":"Stuart, D. I., Ren, J., Wang, X., Rao, Z., & Fry, E. E. (2019). Hepatitis a virus capsid structure. Cold Spring Harbor Perspectives in Medicine, 9, 1\u201313.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"867_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12917-019-2091-6","volume":"15","author":"T Oh","year":"2019","unstructured":"Oh, T., Park, K. H., Yang, S., Jeong, J., Kang, I., Park, C., & Chae, C. (2019). Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with mycoplasma hyopneumoniae, Pcv2, and Prrsv and the efficacy comparison of the respective monovalent vaccines against a single challenge. BMC Veterinary Research, 15, 342.","journal-title":"BMC Veterinary Research"},{"key":"867_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0264-410X(94)90125-2","volume":"12","author":"JD Hunt","year":"1994","unstructured":"Hunt, J. D., Jackson, D. C., Brown, L. E., Wood, P. R., & Stewart, D. J. (1994). Antigenic competition in a multivalent foot rot vaccine. Vaccine, 12, 457\u2013464.","journal-title":"Vaccine"},{"key":"867_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.fsi.2018.02.022","volume":"75","author":"ZX Cheng","year":"2018","unstructured":"Cheng, Z. X., Chu, X., Wang, S. N., Peng, X. X., & Li, H. (2018). Six genes of ompa family shuffling for development of polyvalent vaccines against vibrio alginolyticus and edwardsiella tarda. Fish & Shellfish Immunology, 75, 308\u2013315.","journal-title":"Fish & Shellfish Immunology"},{"key":"867_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fsi.2017.10.046","volume":"72","author":"B Peng","year":"2018","unstructured":"Peng, B., Lin, X. P., Wang, S. N., Yang, M. J., Peng, X. X., & Li, H. (2018). Polyvalent protective immunogens identified from outer membrane proteins of vibrio parahaemolyticus and their induced innate immune response. Fish & Shellfish Immunology, 72, 104\u2013110.","journal-title":"Fish & Shellfish Immunology"},{"key":"867_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1586\/14760584.2016.1150182","volume":"15","author":"M Bakker","year":"2016","unstructured":"Bakker, M., Bunge, E. M., Marano, C., de Ridder, M., & De Moerlooze, L. (2016). Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: A systematic literature review. Expert Review of Vaccines, 15, 829\u2013851.","journal-title":"Expert Review of Vaccines"},{"key":"867_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms24021701","volume":"24","author":"A Kovalenko","year":"2023","unstructured":"Kovalenko, A., Ryabchevskaya, E., Evtushenko, E., Nikitin, N., & Karpova, O. (2023). Recombinant protein vaccines against human betacoronaviruses: strategies, approaches and progress. International Journal of Molecular Sciences, 24, 1\u201334.","journal-title":"International Journal of Molecular Sciences"},{"key":"867_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.health.2022.100044","volume":"2","author":"DD Martinelli","year":"2022","unstructured":"Martinelli, D. D. (2022). In silico vaccine design: A tutorial in immunoinformatics. Healthcare Analytics, 2, 4\u201316.","journal-title":"Healthcare Analytics"},{"key":"867_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1586\/14760584.6.6.891","volume":"6","author":"J Beran","year":"2007","unstructured":"Beran, J. (2007). Bivalent inactivated hepatitis a and recombinant hepatitis B vaccine. Expert Review of Vaccines, 6, 891\u2013902.","journal-title":"Expert Review of Vaccines"},{"key":"867_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biomaterials.2017.05.001","volume":"136","author":"T Courant","year":"2017","unstructured":"Courant, T., Bayon, E., Reynaud-Dougier, H. L., Villiers, C., Menneteau, M., Marche, P. N., & Navarro, F. P. (2017). Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies. Biomaterials, 136, 29\u201342.","journal-title":"Biomaterials"},{"key":"867_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2264","volume":"13","author":"AJ McMichael","year":"2012","unstructured":"McMichael, A. J., & Haynes, B. F. (2012). Lessons Learned from Hiv-1 vaccine trials: New priorities and directions. Nature Immunology, 13, 423\u2013427.","journal-title":"Nature Immunology"},{"key":"867_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12865-021-00412-0","volume":"22","author":"YA Almofti","year":"2021","unstructured":"Almofti, Y. A., Abd-Elrahman, K. A., & Eltilib, E. E. M. (2021). Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory Syndrome Coronavirus-2 (Sars-Cov-2). BMC Immunology, 22, 22.","journal-title":"BMC Immunology"},{"key":"867_CR38","first-page":"21","volume":"10","author":"AM Rabie","year":"2018","unstructured":"Rabie, A. M., Tantawy, A. S., & Badr, S. M. I. (2018). Design, synthesis, and biological evaluation of new 5-substituted-1,3,4-thiadiazole-2-thiols as potent antioxidants. Researcher, 10, 21\u201343.","journal-title":"Researcher"},{"key":"867_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5923\/j.ajoc.20160602.02","volume":"6","author":"AM Rabie","year":"2016","unstructured":"Rabie, A. M., Tantawy, A. S., & Badr, S. M. I. (2016). Synthesis, and Biological Evaluation of Novel 5-Substituted-2-(3,4,5-Trihydroxyphenyl)-1,3,4-Oxadiazoles as Potent Antioxidants. Am J Org Chem, 6, 54\u201380.","journal-title":"Am J Org Chem"},{"key":"867_CR40","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkaa1023","volume":"49","author":"EW Sayers","year":"2021","unstructured":"Sayers, E. W., Cavanaugh, M., Clark, K., Pruitt, K. D., Schoch, C. L., Sherry, S. T., & Karsch-Mizrachi, I. (2021). Genbank. Nucleic Acids Research, 49, D92\u2013D96.","journal-title":"Nucleic Acids Research"},{"key":"867_CR41","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K Tamura","year":"2013","unstructured":"Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013). Mega6: molecular evolutionary genetics analysis version 6.0. Molecular Biology and Evolution, 30, 2725\u20132729.","journal-title":"Molecular Biology and Evolution"},{"key":"867_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00251-004-0709-7","volume":"56","author":"PA Reche","year":"2004","unstructured":"Reche, P. A., Glutting, J. P., Zhang, H., & Reinherz, E. L. (2004). Enhancement to the rankpep resource for the prediction of peptide binding to mhc molecules using profiles. Immunogenetics, 56, 405\u2013419.","journal-title":"Immunogenetics"},{"key":"867_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","volume":"62","author":"T Stranzl","year":"2010","unstructured":"Stranzl, T., Larsen, M. V., Lundegaard, C., & Nielsen, M. (2010). Netctlpan: Pan-specific Mhc class I pathway epitope predictions. Immunogenetics, 62, 357\u2013368.","journal-title":"Immunogenetics"},{"key":"867_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jim.2013.10.003","volume":"400\u2013401","author":"S Giguere","year":"2013","unstructured":"Giguere, S., Drouin, A., Lacoste, A., Marchand, M., Corbeil, J., & Laviolette, F. (2013). Mhc-Np: Predicting peptides naturally processed by the Mhc. Journal of Immunological Methods, 400\u2013401, 30\u201336.","journal-title":"Journal of Immunological Methods"},{"key":"867_CR45","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2019). The Immune Epitope Database (Iedb): 2018 Update. Nucleic Acids Research, 47, D339\u2013D343.","journal-title":"Nucleic Acids Research"},{"key":"867_CR46","first-page":"55","volume":"3","author":"M Shaiegan","year":"2011","unstructured":"Shaiegan, M., Yari, F., Abolghasemi, H., Bagheri, N., Paridar, M., Heidari, A., Kaskani, S., Sabaghi, F., Dikloo, F., & Zaman-Vaziri, M. (2011). Allele frequencies of Hla-a, B and Drb1 among people of fars ethnicity living in Tehran. IJBC, 3, 55\u201359.","journal-title":"IJBC"},{"key":"867_CR47","first-page":"940","volume":"20","author":"A Esmaeili","year":"2017","unstructured":"Esmaeili, A., Rabe, S. Z. T., Mahmoudi, M., & Rastin, M. (2017). Frequencies of Hla-a, B and Drb1 Alleles in a large normal population living in the city of Mashhad, Northeastern Iran. Iranian Journal of Basic Medical Sciences, 20, 940\u2013943.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"867_CR48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","volume":"25","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A., & Flower, D. R. (2007). Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine, 25, 856\u2013866.","journal-title":"Vaccine"},{"key":"867_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A., & Flower, D. R. (2007). Vaxijen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8, 4.","journal-title":"BMC Bioinformatics"},{"key":"867_CR50","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan, C. N., Zeller, M., Kayala, M. A., Vigil, A., Randall, A., Felgner, P. L., & Baldi, P. (2010). High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics, 26, 2936\u20132943.","journal-title":"Bioinformatics"},{"key":"867_CR51","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017). Bepipred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research, 45, W24\u2013W29.","journal-title":"Nucleic Acids Research"},{"key":"867_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y El-Manzalawy","year":"2008","unstructured":"El-Manzalawy, Y., Dobbs, D., & Honavar, V. (2008). Predicting linear B-cell epitopes using string kernels. Journal of Molecular Recognition, 21, 243\u2013255.","journal-title":"Journal of Molecular Recognition"},{"key":"867_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JE Larsen","year":"2006","unstructured":"Larsen, J. E., Lund, O., & Nielsen, M. (2006). Improved method for predicting linear B-cell epitopes. Immunome Research, 2, 2.","journal-title":"Immunome Research"},{"key":"867_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha, S., & Raghava, G. P. (2006). Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins, 65, 40\u201348.","journal-title":"Proteins"},{"key":"867_CR55","doi-asserted-by":"publisher","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","volume":"38","author":"R Vita","year":"2010","unstructured":"Vita, R., Zarebski, L., Greenbaum, J. A., Emami, H., Hoof, I., Salimi, N., Damle, R., Sette, A., & Peters, B. (2010). The immune epitope database 2.0. Nucleic Acids Research, 38, D854-862.","journal-title":"Nucleic Acids Research"},{"key":"867_CR56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/jvi.55.3.836-839.1985","volume":"55","author":"EA Emini","year":"1985","unstructured":"Emini, E. A., Hughes, J. V., Perlow, D. S., & Boger, J. (1985). Induction of hepatitis a virus-neutralizing antibody by a virus-specific synthetic peptide. Journal of Virology, 55, 836\u2013839.","journal-title":"Journal of Virology"},{"key":"867_CR57","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui, H. H., Sidney, J., Li, W., Fusseder, N., & Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics, 8, 361.","journal-title":"BMC Bioinformatics"},{"key":"867_CR58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1073\/pnas.83.2.226","volume":"83","author":"J Novotny","year":"1986","unstructured":"Novotny, J., Handschumacher, M., Haber, E., Bruccoleri, R. E., Carlson, W. B., Fanning, D. W., Smith, J. A., & Rose, G. D. (1986). Antigenic determinants in proteins coincide with surface regions accessible to large probes (Antibody Domains). Proceedings of the National Academy of Sciences U S A, 83, 226\u2013230.","journal-title":"Proceedings of the National Academy of Sciences U S A"},{"key":"867_CR59","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/bi00367a013","volume":"25","author":"JM Parker","year":"1986","unstructured":"Parker, J. M., Guo, D., & Hodges, R. S. (1986). New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-Ray-derived accessible sites. Biochemistry, 25, 5425\u20135432.","journal-title":"Biochemistry"},{"key":"867_CR60","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J., Bui, H. H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. (2008). Ellipro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics, 9, 514.","journal-title":"BMC Bioinformatics"},{"issue":"Suppl 6","key":"867_CR61","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","volume":"14","author":"I Dimitrov","year":"2013","unstructured":"Dimitrov, I., Flower, D. R., & Doytchinova, I. (2013). Allertop\u2013a server for in silico prediction of allergens. BMC Bioinformatics, 14(Suppl 6), S4.","journal-title":"BMC Bioinformatics"},{"key":"867_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Discovery, O. S. D., & C. and Raghava, G. P. (2013). In silico approach for predicting toxicity of peptides and proteins. PLoS ONE, 8, e73957.","journal-title":"PLoS ONE"},{"key":"867_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui, H. H., Sidney, J., Dinh, K., Southwood, S., Newman, M. J., & Sette, A. (2006). Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics, 7, 153.","journal-title":"BMC Bioinformatics"},{"key":"867_CR64","first-page":"531","volume":"112","author":"MR Wilkins","year":"1999","unstructured":"Wilkins, M. R., Gasteiger, E., Bairoch, A., Sanchez, J. C., Williams, K. L., Appel, R. D., & Hochstrasser, D. F. (1999). Protein identification and analysis tools in the expasy server. Methods in Molecular Biology, 112, 531\u2013552.","journal-title":"Methods in Molecular Biology"},{"key":"867_CR65","first-page":"681","volume":"11","author":"C Geourjon","year":"1995","unstructured":"Geourjon, C., & Del\u00e9age, G. (1995). Sopma: Significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Computer Applications in the Biosciences, 11, 681\u2013684.","journal-title":"Computer Applications in the Biosciences"},{"key":"867_CR66","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/bioinformatics\/14.10.892","volume":"14","author":"JA Cuff","year":"1998","unstructured":"Cuff, J. A., Clamp, M. E., Siddiqui, A. S., Finlay, M., & Barton, G. J. (1998). Jpred: A consensus secondary structure prediction server. Bioinformatics, 14, 892\u2013893.","journal-title":"Bioinformatics"},{"key":"867_CR67","doi-asserted-by":"publisher","first-page":"W230","DOI":"10.1093\/nar\/gki412","volume":"33","author":"F Ferr\u00e8","year":"2005","unstructured":"Ferr\u00e8, F., & Clote, P. (2005). Dianna: A web server for disulfide connectivity prediction. Nucleic Acids Research, 33, W230-232.","journal-title":"Nucleic Acids Research"},{"key":"867_CR68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. (2008). I-Tasser server for protein 3d structure prediction. BMC Bioinformatics, 9, 40.","journal-title":"BMC Bioinformatics"},{"key":"867_CR69","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/prot.21968","volume":"72","author":"Y Yang","year":"2008","unstructured":"Yang, Y., & Zhou, Y. (2008). Specific interactions for Ab initio folding of protein terminal regions with secondary structures. Proteins, 72, 793\u2013803.","journal-title":"Proteins"},{"key":"867_CR70","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo, L., Park, H., & Seok, C. (2013). Galaxyrefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41, W384-388.","journal-title":"Nucleic Acids Research"},{"key":"867_CR71","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M., & Sippl, M. J. (2007). Prosa-Web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35, W407-410.","journal-title":"Nucleic Acids Research"},{"key":"867_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B., Arendall, W. B., 3rd., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010). Molprobity: All-atom structure validation for macromolecular crystallography. Acta Crystallographica. Section D, Biological Crystallography, 66, 12\u201321.","journal-title":"Acta Crystallographica. Section D, Biological Crystallography"},{"key":"867_CR73","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester, S. N., & Li, K. (2014). Toll-like receptors in antiviral innate immunity. Journal of Molecular Biology, 426, 1246\u20131264.","journal-title":"Journal of Molecular Biology"},{"key":"867_CR74","doi-asserted-by":"publisher","first-page":"D392","DOI":"10.1093\/nar\/gkq1021","volume":"39","author":"PW Rose","year":"2011","unstructured":"Rose, P. W., Beran, B., Bi, C., Bluhm, W. F., Dimitropoulos, D., Goodsell, D. S., Prlic, A., Quesada, M., Quinn, G. B., Westbrook, J. D., Young, J., Yukich, B., Zardecki, C., Berman, H. M., & Bourne, P. E. (2011). The Rcsb protein data bank: Redesigned web site and web services. Nucleic Acids Research, 39, D392-401.","journal-title":"Nucleic Acids Research"},{"key":"867_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The cluspro web server for protein-protein docking. Nature Protocols, 12, 255\u2013278.","journal-title":"Nature Protocols"},{"key":"867_CR76","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi, M., Peters, B., Pasquetto, V., Tscharke, D. C., Sidney, J., Bui, H. H., Grey, H., & Sette, A. (2006). A consensus epitope prediction approach identifies the breadth of murine T(Cd8+)-cell responses to vaccinia virus. Nature Biotechnology, 24, 817\u2013819.","journal-title":"Nature Biotechnology"},{"key":"867_CR77","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1128\/JVI.02632-06","volume":"81","author":"MF Kotturi","year":"2007","unstructured":"Kotturi, M. F., Peters, B., Buendia-Laysa, F., Jr., Sidney, J., Oseroff, C., Botten, J., Grey, H., Buchmeier, M. J., & Sette, A. (2007). The Cd8+ T-cell response to lymphocytic choriomeningitis virus involves the L Antigen: Uncovering new tricks for an old virus. Journal of Virology, 81, 4928\u20134940.","journal-title":"Journal of Virology"},{"key":"867_CR78","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang, P., Sidney, J., Kim, Y., Sette, A., Lund, O., Nielsen, M., & Peters, B. (2010). Peptide binding predictions for Hla Dr, Dp and Dq molecules. BMC Bioinformatics, 11, 568.","journal-title":"BMC Bioinformatics"},{"key":"867_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104388","volume":"84","author":"D Chaudhuri","year":"2020","unstructured":"Chaudhuri, D., Datta, J., Majumder, S., & Giri, K. (2020). In silico designing of peptide based vaccine for hepatitis viruses using reverse vaccinology approach. Infection, Genetics and Evolution, 84, 104388.","journal-title":"Infection, Genetics and Evolution"},{"key":"867_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4149\/av_2018_107","volume":"62","author":"P Kashyap","year":"2018","unstructured":"Kashyap, P., Deka, M., Medhi, S., Dutta, S., Kashyap, K., & Kumari, N. (2018). Association of toll-like receptor 4 with hepatitis a virus infection in Assam. Acta Virologica, 62, 58\u201362.","journal-title":"Acta Virologica"},{"key":"867_CR81","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.3390\/ijms23105475","volume":"23","author":"MEH Kayesh","year":"2022","unstructured":"Kayesh, M. E. H., Kohara, M., & Tsukiyama-Kohara, K. (2022). Toll-like receptor response to hepatitis C virus infection: A recent overview. International Journal of Molecular Science, 23, 5475.","journal-title":"International Journal of Molecular Science"},{"key":"867_CR82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/cmi.2014.112","volume":"12","author":"Z Ma","year":"2015","unstructured":"Ma, Z., Zhang, E., Yang, D., & Lu, M. (2015). Contribution of toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cellular & Molecular Immunology, 12, 273\u2013282.","journal-title":"Cellular & Molecular Immunology"},{"key":"867_CR83","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/21645515.2020.1769389","volume":"16","author":"L Zhang","year":"2020","unstructured":"Zhang, L. (2020). Hepatitis a Vaccination. Hum Vaccin Immunother, 16, 1565\u20131573.","journal-title":"Hepatitis a Vaccination. Hum Vaccin Immunother"},{"key":"867_CR84","first-page":"E618","volume":"63","author":"M Behzadifar","year":"2022","unstructured":"Behzadifar, M., Azari, S., Shirkhani, S., Gholamrezaei, S., Shahabi, S., Doshmangir, L., Ehsanzadeh, S. J., Martini, M., Bragazzi, N. L., & Behzadifar, M. (2022). Hepatitis B vaccination in Iran: Historical policies and programs. Journal of Preventive Medicine and Hygiene, 63, E618\u2013E624.","journal-title":"Journal of Preventive Medicine and Hygiene"},{"key":"867_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15082388","volume":"15","author":"T Stroffolini","year":"2023","unstructured":"Stroffolini, T., & Stroffolini, G. (2023). A historical overview on the role of hepatitis B and C viruses as aetiological factors for hepatocellular carcinoma. Cancers (Basel), 15, 1\u201313.","journal-title":"Cancers (Basel)"},{"key":"867_CR86","first-page":"16","volume-title":"Hepatitis a Virus and Hepatitis E Virus Seroprevalence among Blood Donors in Tehran","author":"K Hesamizadeh","year":"2016","unstructured":"Hesamizadeh, K., Sharafi, H., Keyvani, H., Alavian, S. M., Shabankareh, A. N. T., Olyaie, R. S., & Keshvari, M. (2016). Hepatitis a Virus and Hepatitis E Virus Seroprevalence among Blood Donors in Tehran (p. 16). Hepat Mon."},{"key":"867_CR87","first-page":"288","volume":"16","author":"M Javanian","year":"2022","unstructured":"Javanian, M., Sadeghi, F., Aghajanipour, H., & A., Chehrazi, M. and Yahyapour, Y. (2022). Seroprevalence of hepatitis a and hepatitis E viruses among blood donors in North of Iran. IJMM, 16, 288\u2013295.","journal-title":"IJMM"},{"key":"867_CR88","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1080\/21645515.2016.1216286","volume":"12","author":"S Rao","year":"2016","unstructured":"Rao, S., Mao, J. S., Motlekar, S., Fangcheng, Z., & Kadhe, G. (2016). A review of immunogenicity and tolerability of live attenuated hepatitis a vaccine in children. Human Vaccines & Immunotherapeutics, 12, 3160\u20133165.","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"867_CR89","doi-asserted-by":"crossref","unstructured":"Pinto, R. M., Perez-Rodriguez, F. J., D'Andrea, L., de Castellarnau, M., Guix, S. and Bosch, A. (2018). Hepatitis a virus codon usage: implications for translation kinetics and capsid folding. Cold Spring Harb Perspect Med 8.","DOI":"10.1101\/cshperspect.a031781"},{"key":"867_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12050533","volume":"12","author":"T Kanda","year":"2020","unstructured":"Kanda, T., Sasaki, R., Masuzaki, R., Matsumoto, N., Ogawa, M., & Moriyama, M. (2020). Cell culture systems and drug targets for hepatitis a virus infection. Viruses, 12, 1\u201311.","journal-title":"Viruses"},{"key":"867_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2021.01.001","volume":"170","author":"J Pollet","year":"2021","unstructured":"Pollet, J., Chen, W. H., & Strych, U. (2021). Recombinant protein vaccines, a proven approach against coronavirus pandemics. Advanced Drug Delivery Reviews, 170, 71\u201382.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"867_CR92","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/jvi.52.2.465-473.1984","volume":"52","author":"JV Hughes","year":"1984","unstructured":"Hughes, J. V., Stanton, L. W., Tomassini, J. E., Long, W. J., & Scolnick, E. M. (1984). Neutralizing monoclonal antibodies to hepatitis a virus: Partial localization of a neutralizing antigenic site. Journal of Virology, 52, 465\u2013473.","journal-title":"Journal of Virology"},{"key":"867_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jviromet.2016.02.014","volume":"233","author":"Q Su","year":"2016","unstructured":"Su, Q., Guo, M., Jia, Z., Qiu, F., Lu, X., Gao, Y., Meng, Q., Tian, R., Bi, S., & Yi, Y. (2016). Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis a virus vaccines. Journal of Virological Methods, 233, 41\u201345.","journal-title":"Journal of Virological Methods"},{"key":"867_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0168-1702(88)90022-6","volume":"10","author":"SA Harmon","year":"1988","unstructured":"Harmon, S. A., Johnston, J. M., Ziegelhoffer, T., Richards, O. C., Summers, D. F., & Ehrenfeld, E. (1988). Expression of hepatitis a virus capsid sequences in insect cells. Virus Research, 10, 273\u2013280.","journal-title":"Virus Research"},{"key":"867_CR95","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1128\/jvi.61.11.3645-3647.1987","volume":"61","author":"R Ostermayr","year":"1987","unstructured":"Ostermayr, R., Helm, K., & v. d., Gauss-M\u00fcller, V., Winnacker, E. L. and Deinhardt, F. (1987). Expression of hepatitis a virus Cdna in Escherichia Coli: Antigenic Vp1 recombinant protein. Journal of Virology, 61, 3645\u20133647.","journal-title":"Journal of Virology"},{"key":"867_CR96","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00299-011-1062-6","volume":"30","author":"HY Chung","year":"2011","unstructured":"Chung, H. Y., Lee, H. H., Kim, K. I., Chung, H. Y., Hwang-Bo, J., Park, J. H., Sunter, G., Kim, J. B., Shon, D. H., Kim, W., & Chung, I. S. (2011). Expression of a recombinant chimeric protein of hepatitis a virus Vp1-Fc using a replicating vector based on beet curly top virus in tobacco leaves and its immunogenicity in mice. Plant Cell Reports, 30, 1513\u20131521.","journal-title":"Plant Cell Reports"},{"key":"867_CR97","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jceh.2017.12.010","volume":"8","author":"A Kumar","year":"2018","unstructured":"Kumar, A., Pandey, R., Yadav, I. S., & Bharadwaj, M. (2018). Structural and epitope analysis (T- and B-Cell Epitopes) of hepatitis C virus (Hcv) glycoproteins: An in silico approach. Journal of Clinical and Experimental Hepatology, 8, 352\u2013361.","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"867_CR98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder, R. A., Darrah, P. A., & Roederer, M. (2008). T-cell quality in memory and protection: Implications for vaccine design. Nature Reviews Immunology, 8, 247\u2013258.","journal-title":"Nature Reviews Immunology"},{"key":"867_CR99","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jhep.2010.07.010","volume":"54","author":"I Schulte","year":"2011","unstructured":"Schulte, I., Hitziger, T., Giugliano, S., Timm, J., Gold, H., Heinemann, F. M., Khudyakov, Y., Strasser, M., K\u00f6nig, C., Castermans, E., Mok, J. Y., van Esch, W. J., Bertoletti, A., Schumacher, T. N., & Roggendorf, M. (2011). Characterization of Cd8+ T-cell response in acute and resolved hepatitis a virus infection. Journal of Hepatology, 54, 201\u2013208.","journal-title":"Journal of Hepatology"},{"key":"867_CR100","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jhep.2021.07.019","volume":"75","author":"I Misumi","year":"2021","unstructured":"Misumi, I., Mitchell, J. E., Lund, M. M., Cullen, J. M., Lemon, S. M., & Whitmire, J. K. (2021). T cells protect against hepatitis a virus infection and limit infection-induced liver injury. Journal of Hepatology, 75, 1323\u20131334.","journal-title":"Journal of Hepatology"},{"key":"867_CR101","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2022-0048","author":"SM Hamed","year":"2023","unstructured":"Hamed, S. M., Sakr, M. M., El-Housseiny, G. S., Wasfi, R., & Aboshanab, K. M. (2023). State of the art in epitope mapping and opportunities in Covid-19. Future Science OA. https:\/\/doi.org\/10.2144\/fsoa-2022-0048","journal-title":"Future Science OA"},{"key":"867_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pep.2014.04.011","volume":"100","author":"KO Jang","year":"2014","unstructured":"Jang, K. O., Park, J. H., Lee, H. H., Chung, D. K., Kim, W., & Chung, I. S. (2014). Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein Vp1 for developing subunit vaccine material against hepatitis a virus. Protein Expression and Purification, 100, 1\u20139.","journal-title":"Protein Expression and Purification"},{"key":"867_CR103","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jmii.2022.01.004","volume":"55","author":"YL Huang","year":"2022","unstructured":"Huang, Y. L., Lin, T. M., Wang, S. Y., & Wang, J. R. (2022). The role of conserved arginine and proline residues in enterovirus Vp1 protein. Journal of Microbiology, Immunology, and Infection, 55, 590\u2013597.","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"key":"867_CR104","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1073\/pnas.0711580105","volume":"105","author":"M Lerch-Bader","year":"2008","unstructured":"Lerch-Bader, M., Lundin, C., Kim, H., Nilsson, I., Heijne, G., & v. (2008). Contribution of positively charged flanking residues to the insertion of transmembrane helices into the endoplasmic reticulum. Proceedings of the National Academy of Sciences, 105, 4127\u20134132.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"867_CR105","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1479-5876-12-129","volume":"12","author":"E Funk","year":"2014","unstructured":"Funk, E., Kottilil, S., Gilliam, B., & Talwani, R. (2014). Tickling the Tlr7 to cure viral hepatitis. Journal of Translational Medicine, 12, 129.","journal-title":"Journal of Translational Medicine"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00867-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00867-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00867-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:42:45Z","timestamp":1727300565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00867-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00867-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,16]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflict of interest that could negatively influence the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}